NCT00217542 2013-05-03Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By SurgeryNational Cancer Institute (NCI)Phase 1 Completed42 enrolled